Market Place
Sourcing Support
Astrazeneca, Amgen To Pilot FDA`s Real-Time Trial Model
28 Apr 2026 //
FIRSTWORD PHARMA
Repatha Reduces First Major Cardiovascular Event Risk by 31%
29 Mar 2026 //
PR NEWSWIRE
LASEC Names Amgen Official Biotech Partner For FIFA World Cup
05 Dec 2025 //
PR NEWSWIRE
FDA Expands Repatha Use to Adults at Risk of Cardiovascular Event
28 Aug 2025 //
INDPHARMAPOST
Drugmaker Amgen to invest $200 million in India site, CEO says
24 Feb 2025 //
REUTERS
Accumulus Synergy Powers 1st Digitally Generated Dossier Worldwide
05 Feb 2025 //
GLOBENEWSWIRE
AMGEN TO PRESENT AT THE 2024 UBS GLOBAL HEALTHCARE CONFERENCE
08 Nov 2024 //
PR NEWSWIRE
Amgen And Merck Join Academic Clinical Trial Diversity Initiative
16 Sep 2024 //
FIERCE BIOTECH
Big Pharma Backs OAC`s `Your Weight Matters` Campaign Challenge
10 Sep 2024 //
FIERCE PHARMA
5 Obesity Readouts to Watch in the Second Half of 2024
09 Aug 2024 //
BIOSPACE
New Analysis of MRI Shows UPLIZNA Reduced Formation of Spinal Cord Lesions
30 Jun 2023 //
BUSINESSWIRE
Amgen enlists TScan to work on Crohn`s in deal potentially worth $500M+
10 May 2023 //
ENDPTS
Amgen, Lilly, Biohaven migraine brand recall low, study says; & more
23 Nov 2021 //
ENDPTS
Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine meds
20 Nov 2021 //
FIERCEPHARMA
AbbVie, Biohaven, Eli Lilly, Amgen lead push for attention in competitive space
01 Nov 2021 //
ENDPTS
Roche, Takeda, Pfizer rank highest with rare disease patients
04 Oct 2021 //
FIERCEPHARMA
Roche, Takeda, Pfizer rank highest with rare disease patients
04 Oct 2021 //
FIERCEPHARMA
Changing the whole game of drug discovery`: Legendary R&D vet Roger
06 May 2021 //
ENDPTS
Why look for KRAS mutations? New Mirati, Amgen campaigns explain
13 Apr 2021 //
FIEREPHARMA
‘A milestone in oncology’: Amgen’s KRAS-blocking drug proves effective for lung
29 Jan 2021 //
STATNEWS
Aimovig reduces frequency of episodic migraines, five-year data reveals
06 Oct 2020 //
PHARMAFILE
Treating diabetes by silencing IL-2`s inflammatory power
14 Aug 2020 //
FIERCE BIOTEC
Big pharma alliance recruits first patients for unusual COVID-19 study
03 Aug 2020 //
BIOPHARMADIVE
ChemoCentryx Identifies Novel Orally Administered Inhibitor CCX559
24 Jun 2020 //
GLOBENEWSWIRE
A closer look at the race to develop antibody drugs for COVID-19
12 May 2020 //
BIOPHARMADIVE
Health Care Sector Update for 05/16/2019: BLUE,MRTX,AGIO,EDAP,AMGN
16 May 2019 //
NASDAQ
Imago BioSciences Announces $40 Million Series B Financing
22 Mar 2019 //
BUSINESSWIRE
Amgen, Servier heart failure drug clears trial hurdle
20 Mar 2019 //
PMLIVE
Clinigen to report sharp jump in revenue and profit after busy six months
14 Jan 2019 //
PROACTIVE INVESTORS
Horizon Pharma Announces FDA Approval of RAVICTI® (glycerol phenylbutyrate) Oral
28 Dec 2018 //
BUSINESSWIRE
Amgen, Molecular Partners Enter Immunotherapy Alliance
28 Dec 2018 //
CONTRACT PHARMA
Amgen And Molecular Partners Announce Strategic Collaboration In Immuno-Oncology
18 Dec 2018 //
BIOSPACE
NeuClone Announces its 6th Biosimilar Candidate Perjeta for use in Combination Therapy with Herceptin
18 Dec 2018 //
PR NEWSWIRE
Amgen teams with Entera to develop oral biologics
11 Dec 2018 //
FIERCE BIOTECH
Mini-Exodus From Biosimilar Space Stirs Questions
06 Dec 2018 //
RAPS
ASH18: Amgen’s anti-BCMA bispecific shines again, but CAR-T threat remains
05 Dec 2018 //
FIERCE BIOTECH
Coherus reveals biosimilar launch tactics in battle against Amgen’s Neulasta
08 Nov 2018 //
FIERCE PHARMA
Coherus` newly minted Neulasta biosim steps up pressure on Amgen
06 Nov 2018 //
FIERCE PHARMA
Biosim pain hits Roche and is coming for AbbVie, J&J: report
25 Oct 2018 //
FIERCE PHARMA
ENBREL (Etanercept) Mono & Combination Therapy Both Superior to Methotrexate
23 Oct 2018 //
PR NEWSWIRE
Amgen, Sandoz begin biosimilar trial with top-selling Enbrel at stake
14 Sep 2018 //
BIOPHARMA DIVE
Collaboration of GNS Healthcare, Amgen & Clinical Trials in Oncology
06 Sep 2018 //
PR NEWSWIRE
Editas CMO exit, CRISPR tech gears up; Roche diagnostics CEO out
01 Sep 2018 //
ENDPTS
Preparing for the big biologic switch
17 Aug 2018 //
PHARMACEUTICAL JOURNAL
Brain’s lymphatic system linked to aging and Alzheimer’s
27 Jul 2018 //
FIERCE BIOTECH
Could an old RA drug make CAR-T treatments safer?
07 Jun 2018 //
FIERCE BIOTECH
Ph3 KYPROLIS® (carfilzomib) Regimen In Patients With R/R Multiple Myeloma
01 Jun 2018 //
PR NEWSWIRE
Esperion`s LDL drug aces a third pivotal trial
24 May 2018 //
FIERCE BIOTECH
The Multiple Myeloma Research & Partners Announce To Raise Funds Cancer Research
02 May 2018 //
BUSINESSWIRE
Canadian Government is Investigating Price of Genetic Disease Treatment
27 Mar 2018 //
RAPS
Drug makers jostle over potential Medicare changes in congressional spending
16 Mar 2018 //
STATNEWS
3 Big Drugmakers With Huge Catalysts on the Horizon
31 Jan 2018 //
BIOSPACE
5 Top Biotech Stocks That Look Vulnerable in 2018
09 Jan 2018 //
BIOSACE
Oncolytic viruses show promise in cancer-killing combos
04 Jan 2018 //
FIERCE BIOTECH
World`s Top 5 Best-Selling Drugs in 2017
18 Dec 2017 //
BIOSPACE
Repatha® Ph3 Cognitive Function Study Results Published
16 Aug 2017 //
PR NEWSWIRE
Will These Cutting-Edge Cancer Killers Reignite The Biotech Rally?
15 Jun 2017 //
NASDAQ
First-in-class drug for ovarian cancer shows promise at ASCO
05 Jun 2017 //
FIERCE BIOTECH
A New Antibody For Treating Acute Lymphocytic Leukemia?
06 Dec 2016 //
FORBES
Amgen strikes $674M cardiovascular RNAi pact with Arrowhead
29 Sep 2016 //
FIERCE BIOTECH
